309.5K XNAS Volume
XNAS 18 Mar, 2025 1:51 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 19 Feb 2025 | 2,159 | 170,270 | - | 1.2 | 2,483 | Common Stock |
| Jaume Pons | PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 19 Feb 2025 | 1,326 | 579,388 | - | 1.2 | 1,525 | Common Stock |
| Shelly Pinto | SVP, FINANCE AND CAO | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 19 Feb 2025 | 550 | 87,352 | - | 1.2 | 633 | Common Stock |
| Corey S. Goodman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,400 | 40,400 | - | - | Stock Option (right to buy) | |
| Barbara Klencke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,400 | 40,400 | - | - | Stock Option (right to buy) | |
| Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 478,000 | 478,000 | - | - | Employee Stock Option (right to buy) | |
| Chris H. Takimoto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,400 | 40,400 | - | - | Common Stock (right to buy) | |
| Rekha Hemrajani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 40,400 | 40,400 | - | - | Stock Option (right to buy) | |
| Jaume Pons | PRESIDENT & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 50,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Shelly Pinto | SVP, FINANCE AND CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 112,000 | 112,000 | - | - | Employee Stock Option (right to buy) | |
| Harish Shantharam | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Shelly Pinto | Interim CFO | Sale of securities on an exchange or to another person at price $ 1.80 per share. | 06 Jan 2025 | 2,221 | 87,902 | - | 1.8 | 3,998 | Common Stock |
| Jaume Pons | PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 30 Dec 2024 | 10,796 | 580,714 | - | 1.6 | 17,060 | Common Stock |
| Shelly Pinto | Interim CFO | Sale of securities on an exchange or to another person at price $ 1.58 per share. | 30 Dec 2024 | 1,426 | 90,123 | - | 1.6 | 2,253 | Common Stock |
| Hemrajani Rekha | Director | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 02 Dec 2024 | 30,000 | 33,000 | - | 1.5 | 46,404 | Common Stock |
| Lettmann Jason | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 200,000 | 200,000 | - | - | Employee Stock Option (right to buy) | |
| Shelly Pinto | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2024 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2024 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Peter S. Garcia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. | 14 Aug 2024 | 761 | 121,516 | - | 2.6 | 1,963 | Common Stock |
| Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.58 per share. | 14 Aug 2024 | 2,191 | 169,429 | - | 2.6 | 5,653 | Common Stock |
| Jaume Pons | PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 14 Aug 2024 | 1,937 | 591,510 | - | 2.6 | 4,997 | Common Stock |
| Sophia Randolph | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 14 Aug 2024 | 1,365 | 325,711 | - | 2.6 | 3,522 | Common Stock |
| Shelly Pinto | SVP, FINANCE AND CAO | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 14 Aug 2024 | 564 | 91,549 | - | 2.6 | 1,455 | Common Stock |
| Alan B. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 40,400 | 40,400 | - | - | Stock Option (right to buy) | |
| Jaume Pons | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 11 Jul 2024 | 20,000 | 613,447 | - | 1.0 | 19,800 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2024 | 20,000 | 144,433 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 7.90 per share. | 11 Jul 2024 | 20,000 | 593,447 | - | 7.9 | 158,076 | Common Stock |
| Shelly Pinto | SVP, FINANCE AND CAO | Sale of securities on an exchange or to another person at price $ 5.50 per share. | 05 Jul 2024 | 1,823 | 92,113 | - | 5.5 | 10,025 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 01 Jul 2024 | 10,758 | 593,447 | - | 5.8 | 62,599 | Common Stock |
| Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 01 Jul 2024 | 3,273 | 327,076 | - | 5.8 | 19,045 | Common Stock |
| Shelly Pinto | SVP, FINANCE AND CAO | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 01 Jul 2024 | 1,373 | 93,936 | - | 5.8 | 7,989 | Common Stock |
| Peter S. Garcia | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 28 Jun 2024 | 1,789 | 122,277 | - | 6.0 | 10,788 | Common Stock |
| Corey S. Goodman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 20,200 | 20,200 | - | - | Stock Option (right to buy) | |
| Peter S. Garcia | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 8.53 per share. | 13 Jun 2024 | 12,000 | 122,348 | - | 8.5 | 102,338 | Common Stock |
| Rekha Hemrajani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 20,200 | 20,200 | - | - | Stock Option (right to buy) | |
| Peter S. Garcia | CHIEF FINANCIAL OFFICER | Purchase of securities on an exchange or from another person at price $ 8.53 per share. | 13 Jun 2024 | 12,000 | 122,348 | - | 8.5 | 102,338 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 20,000 | 164,433 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 8.43 per share. | 04 Jun 2024 | 20,000 | 604,205 | - | 8.4 | 168,652 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 04 Jun 2024 | 20,000 | 624,205 | - | 1.0 | 19,800 | Common Stock |
| Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 16.67 per share. | 13 May 2024 | 1,797 | 330,349 | - | 16.7 | 29,959 | Common Stock |
| Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 13 May 2024 | 10,203 | 332,146 | - | 15.8 | 161,380 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 20,000 | 184,433 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 15.92 per share. | 06 May 2024 | 20,000 | 604,205 | - | 15.9 | 318,334 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 06 May 2024 | 20,000 | 624,205 | - | 1.0 | 19,800 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 16 Apr 2024 | 25,846 | 654,205 | - | 1.0 | 25,588 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 25,846 | 204,433 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 16 Apr 2024 | 50,000 | 604,205 | - | 14.2 | 710,195 | Common Stock |
| Jaume Pons | Director, PRESIDENT & CSO | Sale of securities on an exchange or to another person at price $ 11.15 per share. | 04 Apr 2024 | 20,000 | 628,359 | - | 11.2 | 223,036 | Common Stock |
| Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 11.31 per share. | 14 Mar 2024 | 4,400 | 171,620 | - | 11.3 | 49,771 | Common Stock |
| Pinto Shelly | SVP, FINANCE AND CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 35,000 | 35,000 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, PRESIDENT & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,000 | 648,359 | - | 0 | Common Stock | |
| Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,000 | 342,349 | - | 0 | Common Stock | |
| Shelly Pinto | SVP, FINANCE AND CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 15,000 | 93,591 | - | 0 | Common Stock | |
| Garcia Peter S. | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
| Randolph Sophia | Director, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Lettmann Jason | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 60,000 | 167,220 | - | 0 | Common Stock | |
| Jaume Pons | Director, PRESIDENT & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Garcia S. Peter | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 25,000 | 110,348 | - | 0 | Common Stock | |
| Jason Lettmann | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 190,000 | 190,000 | - | - | Employee Stock Option | |
| Pinto Shelly | SVP, Finance and CAO | Sale of securities on an exchange or to another person at price $ 13.60 per share. | 04 Jan 2024 | 2,717 | 78,591 | - | 13.6 | 36,957 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 29 Dec 2023 | 3,128 | 312,349 | - | 15.0 | 47,045 | Common Stock |
| Pons Jaume | Director, President & CSO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 29 Dec 2023 | 7,179 | 618,359 | - | 15.0 | 107,972 | Common Stock |
| Pinto Shelly | SVP, Finance and CAO | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 29 Dec 2023 | 1,631 | 81,308 | - | 15.0 | 24,530 | Common Stock |
| Garcia S. Peter | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 29 Dec 2023 | 1,893 | 85,348 | - | 15.0 | 28,471 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 32,000 | 86,738 | - | 0 | Common Stock | |
| Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 101,000 | 101,000 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 89,000 | 625,538 | - | 0 | Common Stock | |
| Jaume Pons | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 282,000 | 282,000 | - | - | Employee Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 34,000 | 315,477 | - | - | Common Stock | |
| Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 107,000 | 107,000 | - | - | Common Stock | |
| Shelly Pinto | SVP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 36,000 | 36,000 | - | - | Employee Stock Option (right to buy) | |
| Shelly Pinto | SVP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 26,000 | 81,713 | - | 0 | Common Stock | |
| Shelly Pinto | VP, Finance and CAO | Sale of securities on an exchange or to another person at price $ 6.52 per share. | 06 Jul 2023 | 7,345 | 55,713 | - | 6.5 | 47,889 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 30 Jun 2023 | 887 | 54,738 | - | 7.3 | 6,511 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 30 Jun 2023 | 3,208 | 536,538 | - | 7.3 | 23,547 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 30 Jun 2023 | 1,605 | 281,477 | - | 7.3 | 11,781 | Common Stock |
| Shelly Pinto | VP, Finance and CAO | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 30 Jun 2023 | 466 | 63,058 | - | 7.3 | 3,420 | Common Stock |
| Corey S. Goodman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 20,200 | 20,200 | - | - | Stock Option (right to buy) | |
| Jack Bech Nielsen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 20,200 | 20,200 | - | - | Stock Option (right to buy) | |
| Jason Lettmann | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 20,200 | 20,200 | - | - | Stock option (right to buy) | |
| Rekha Hemrajani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 20,200 | 20,200 | - | - | Stock Option (right to buy) | |
| Itziar Canamasas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 20,200 | 20,200 | - | - | Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 09 Jun 2023 | 4,027 | 274,280 | - | 1.9 | 7,692 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 6,256 | 19,084 | - | - | Employee Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 2,546 | 92,629 | - | - | Employee Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 4,027 | 0 | - | - | Employee Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.81 per share. | 09 Jun 2023 | 6,256 | 283,082 | - | 4.8 | 30,091 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 09 Jun 2023 | 2,546 | 276,826 | - | 4.1 | 10,388 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 29 Dec 2022 | 893 | 53,723 | - | 11.1 | 9,886 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 29 Dec 2022 | 3,232 | 539,746 | - | 11.1 | 35,779 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 29 Dec 2022 | 1,617 | 270,253 | - | 11.1 | 17,901 | Common Stock |
| Shelly Pinto | VP, Finance and CAO | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 29 Dec 2022 | 482 | 62,097 | - | 11.1 | 5,336 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.81 per share. | 16 Dec 2022 | 25,339 | 271,870 | - | 4.8 | 121,881 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 16 Dec 2022 | 8,404 | 233,800 | - | 1.9 | 16,052 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 16 Dec 2022 | 12,731 | 246,531 | - | 4.1 | 51,942 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 25,339 | 25,340 | - | - | Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 12,731 | 95,175 | - | - | Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 8,404 | 4,027 | - | - | Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 29,000 | 55,178 | - | 0 | Common Stock | |
| Jaume Pons | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 244,000 | 244,000 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 74,000 | 542,978 | - | 0 | Common Stock | |
| Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 123,000 | 123,000 | - | - | Employee Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 37,000 | 225,396 | - | 0 | Common Stock | |
| Shelly Pinto | VP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 36,000 | 36,000 | - | - | Employee Stock Option (right to buy) | |
| Shelly Pinto | VP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 11,000 | 62,718 | - | 0 | Common Stock | |
| Corey S. Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 12,004 | 12,004 | - | - | Stock Option (right to buy) | |
| Jack Bech Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 12,004 | 12,004 | - | - | Stock Option (right to buy) | |
| Jason Lettmann | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 12,004 | 12,004 | - | - | Common Stock (right to buy) | |
| Rekha Hemrajani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 12,004 | 12,004 | - | - | Stock Option (right to buy) | |
| Itziar Canamasas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,000 | 2,000 | - | - | Stock Option (right to buy) | |
| Itziar Canamasas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2022 | 24,009 | 24,009 | - | - | Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 07 Feb 2022 | 6,637 | 16,120 | - | 4.1 | 27,079 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 8,363 | 20,813 | - | - | Employee Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Feb 2022 | 6,637 | 89,022 | - | - | Employee Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.81 per share. | 07 Feb 2022 | 8,363 | 24,483 | - | 4.8 | 40,226 | Common Stock |
| Jaume Pons | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 03 Feb 2022 | 11,900 | 456,724 | - | 1.0 | 11,781 | Common Stock |
| Jaume Pons | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 12,254 | 6,128 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2022 | 11,900 | 230,279 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 03 Feb 2022 | 12,254 | 468,978 | - | 1.9 | 23,405 | Common Stock |
| Shelly Pinto | VP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 50,000 | 50,446 | - | 0 | Common Stock | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 15 Dec 2021 | 11,059 | 188,396 | - | 1.9 | 21,123 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 15 Dec 2021 | 12,793 | 177,337 | - | 1.0 | 12,665 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2021 | 11,059 | 12,431 | - | - | Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2021 | 12,793 | 0 | - | - | Stock Option (right to buy) | |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 13 Dec 2021 | 60 | 285,956 | - | 30.2 | 1,814 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.23 per share. | 13 Dec 2021 | 440 | 2,097,326 | - | 30.2 | 13,301 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.60 per share. | 13 Dec 2021 | 181 | 286,016 | - | 29.6 | 5,358 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 29.60 per share. | 13 Dec 2021 | 1,329 | 2,097,766 | - | 29.6 | 39,338 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 13 Dec 2021 | 299 | 286,197 | - | 28.4 | 8,483 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.37 per share. | 13 Dec 2021 | 2,196 | 2,099,095 | - | 28.4 | 62,301 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 13 Dec 2021 | 1,296 | 286,496 | - | 27.5 | 35,627 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.49 per share. | 13 Dec 2021 | 286,496 | 2,101,291 | - | 27.5 | 7,875,775 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.48 per share. | 13 Dec 2021 | 2,339 | 287,792 | - | 26.5 | 61,937 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.48 per share. | 13 Dec 2021 | 17,169 | 2,110,800 | - | 26.5 | 454,635 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 13 Dec 2021 | 11,945 | 2,127,969 | - | 25.3 | 302,089 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.29 per share. | 13 Dec 2021 | 1,627 | 290,131 | - | 25.3 | 41,147 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.77 per share. | 22 Nov 2021 | 14,884 | 164,544 | - | 36.8 | 547,314 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 30,000 | 107,906 | - | - | Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 22 Nov 2021 | 30,000 | 179,428 | - | 4.1 | 122,400 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.12 per share. | 19 Oct 2021 | 2,229 | 444,598 | - | 55.1 | 122,866 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.12 per share. | 19 Oct 2021 | 2,229 | 444,598 | - | 55.1 | 122,866 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.17 per share. | 19 Oct 2021 | 14,471 | 446,827 | - | 54.2 | 783,848 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.17 per share. | 19 Oct 2021 | 14,471 | 446,827 | - | 54.2 | 783,848 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 55.15 per share. | 18 Oct 2021 | 1,903 | 11,806 | - | 55.2 | 104,958 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Oct 2021 | 7,229 | 60,468 | - | - | Employee Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 59.06 per share. | 18 Oct 2021 | 189 | 9,331 | - | 59.1 | 11,163 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 58.30 per share. | 18 Oct 2021 | 438 | 9,520 | - | 58.3 | 25,537 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 57.54 per share. | 18 Oct 2021 | 411 | 9,958 | - | 57.5 | 23,648 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 56.09 per share. | 18 Oct 2021 | 1,437 | 10,369 | - | 56.1 | 80,603 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 54.33 per share. | 18 Oct 2021 | 2,851 | 13,709 | - | 54.3 | 154,884 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 18 Oct 2021 | 7,229 | 16,560 | - | 4.1 | 29,494 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.79 per share. | 11 Oct 2021 | 4,948 | 151,867 | - | 60.8 | 300,776 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.36 per share. | 11 Oct 2021 | 2,439 | 149,428 | - | 61.4 | 149,646 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 74.42 per share. | 20 Sep 2021 | 10,322 | 463,247 | - | 74.4 | 768,154 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 73.78 per share. | 20 Sep 2021 | 4,429 | 473,569 | - | 73.8 | 326,754 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 76.46 per share. | 20 Sep 2021 | 235 | 461,298 | - | 76.5 | 17,969 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 75.46 per share. | 20 Sep 2021 | 1,714 | 461,533 | - | 75.5 | 129,336 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 78.31 per share. | 10 Sep 2021 | 1,458 | 156,815 | - | 78.3 | 114,183 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 77.69 per share. | 10 Sep 2021 | 5,029 | 158,273 | - | 77.7 | 390,682 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 76.45 per share. | 10 Sep 2021 | 900 | 163,302 | - | 76.5 | 68,806 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 23 Aug 2021 | 60,000 | 69,331 | - | 4.1 | 244,800 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 70.85 per share. | 23 Aug 2021 | 1,593 | 67,738 | - | 70.9 | 112,872 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 72.03 per share. | 23 Aug 2021 | 3,497 | 64,241 | - | 72.0 | 251,906 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 19,370 | 80,468 | - | - | Employee Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Aug 2021 | 40,630 | 95,659 | - | - | Employee Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 77.57 per share. | 23 Aug 2021 | 35 | 9,331 | - | 77.6 | 2,715 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.66 per share. | 23 Aug 2021 | 2,616 | 9,366 | - | 76.7 | 200,550 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.71 per share. | 23 Aug 2021 | 10,743 | 11,982 | - | 75.7 | 813,317 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.09 per share. | 23 Aug 2021 | 19,448 | 22,725 | - | 75.1 | 1,460,278 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 73.57 per share. | 23 Aug 2021 | 4,008 | 42,173 | - | 73.6 | 294,871 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 72.66 per share. | 23 Aug 2021 | 18,060 | 46,181 | - | 72.7 | 1,312,252 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 67.13 per share. | 17 Aug 2021 | 505 | 11,771 | - | 67.1 | 33,899 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 17 Aug 2021 | 10,000 | 19,331 | - | 4.1 | 40,800 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.24 per share. | 17 Aug 2021 | 4,687 | 14,644 | - | 65.2 | 305,757 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.83 per share. | 17 Aug 2021 | 2,368 | 12,276 | - | 65.8 | 155,892 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 68.34 per share. | 17 Aug 2021 | 2,400 | 9,371 | - | 68.3 | 164,005 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 68.62 per share. | 17 Aug 2021 | 40 | 9,331 | - | 68.6 | 2,745 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Aug 2021 | 10,000 | 136,289 | - | - | Employee Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.20 per share. | 10 Aug 2021 | 1,718 | 169,871 | - | 64.2 | 110,291 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 65.46 per share. | 10 Aug 2021 | 70 | 164,202 | - | 65.5 | 4,582 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.76 per share. | 10 Aug 2021 | 5,599 | 164,272 | - | 64.8 | 362,566 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 225,000 | 225,000 | - | - | Employee Stock Option (right to buy) | |
| Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Shelly Pinto | VP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.37 per share. | 19 Jul 2021 | 9,500 | 500,446 | - | 54.4 | 516,553 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.08 per share. | 19 Jul 2021 | 5,900 | 494,546 | - | 55.1 | 324,984 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 53.62 per share. | 19 Jul 2021 | 1,300 | 509,946 | - | 53.6 | 69,708 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 55.86 per share. | 12 Jul 2021 | 300 | 171,589 | - | 55.9 | 16,757 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 54.86 per share. | 12 Jul 2021 | 7,087 | 171,889 | - | 54.9 | 388,770 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 58.92 per share. | 21 Jun 2021 | 10,353 | 511,246 | - | 58.9 | 609,976 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 58.06 per share. | 21 Jun 2021 | 6,347 | 521,599 | - | 58.1 | 368,504 | Common Stock |
| Corey S. Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock Option (right to buy) | |
| Jack B. Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock Option (right to buy) | |
| Jason Lettmann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock Option (right to buy) | |
| Rekha Hemrajani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock Option (right to buy) | |
| Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 12,004 | 12,004 | - | - | Stock option (right to buy) | |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 55.69 per share. | 19 May 2021 | 15,221 | 528,925 | - | 55.7 | 847,659 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 56.71 per share. | 19 May 2021 | 979 | 527,946 | - | 56.7 | 55,515 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 54.20 per share. | 19 May 2021 | 500 | 544,146 | - | 54.2 | 27,102 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.12 per share. | 10 May 2021 | 4,433 | 187,392 | - | 62.1 | 275,378 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.12 per share. | 10 May 2021 | 1,925 | 191,825 | - | 61.1 | 117,654 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.56 per share. | 10 May 2021 | 73 | 186,363 | - | 64.6 | 4,713 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.79 per share. | 10 May 2021 | 956 | 186,436 | - | 62.8 | 60,026 | Common Stock |
| Shelly Pinto | VP, Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 60.48 per share. | 19 Apr 2021 | 837 | 544,646 | - | 60.5 | 50,618 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 59.52 per share. | 19 Apr 2021 | 663 | 545,483 | - | 59.5 | 39,460 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 58.36 per share. | 19 Apr 2021 | 2,914 | 546,146 | - | 58.4 | 170,054 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 57.73 per share. | 19 Apr 2021 | 6,956 | 549,060 | - | 57.7 | 401,568 | Common Stock |
| Jaume Pons | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 56.42 per share. | 19 Apr 2021 | 5,330 | 556,016 | - | 56.4 | 300,733 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 58.06 per share. | 12 Apr 2021 | 2,903 | 198,234 | - | 58.1 | 168,541 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.29 per share. | 12 Apr 2021 | 2,941 | 194,293 | - | 60.3 | 177,299 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 59.15 per share. | 12 Apr 2021 | 1,000 | 197,234 | - | 59.1 | 59,148 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.59 per share. | 12 Apr 2021 | 259 | 194,034 | - | 61.6 | 15,953 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.51 per share. | 12 Apr 2021 | 284 | 193,750 | - | 63.5 | 18,037 | Common Stock |
| Jaume Pons | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 25 Mar 2021 | 10,000 | 561,346 | - | 1.0 | 9,900 | Common Stock |
| Jaume Pons | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2021 | 10,000 | 242,179 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 64.98 per share. | 22 Mar 2021 | 900 | 565,946 | - | 65.0 | 58,486 | Common Stock |
| Jaume Pons | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 22 Mar 2021 | 16,700 | 568,046 | - | 1.9 | 31,897 | Common Stock |
| Jaume Pons | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 63.79 per share. | 22 Mar 2021 | 1,200 | 566,846 | - | 63.8 | 76,545 | Common Stock |
| Jaume Pons | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 16,700 | 89,019 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 70.12 per share. | 22 Mar 2021 | 600 | 551,346 | - | 70.1 | 42,075 | Common Stock |
| Jaume Pons | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 69.77 per share. | 22 Mar 2021 | 9,200 | 551,946 | - | 69.8 | 641,857 | Common Stock |
| Jaume Pons | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 68.27 per share. | 22 Mar 2021 | 2,700 | 561,146 | - | 68.3 | 184,329 | Common Stock |
| Jaume Pons | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 67.18 per share. | 22 Mar 2021 | 1,500 | 563,846 | - | 67.2 | 100,773 | Common Stock |
| Jaume Pons | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 66.32 per share. | 22 Mar 2021 | 600 | 565,346 | - | 66.3 | 39,795 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 75.20 per share. | 10 Mar 2021 | 1,146 | 201,237 | - | 75.2 | 86,177 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 76.69 per share. | 10 Mar 2021 | 100 | 201,137 | - | 76.7 | 7,669 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 73.38 per share. | 10 Mar 2021 | 1,297 | 207,227 | - | 73.4 | 95,177 | Common Stock |
| Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 74.35 per share. | 10 Mar 2021 | 4,844 | 202,383 | - | 74.3 | 360,151 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 28 Jan 2021 | 6,128 | 9,128 | - | 4.1 | 25,002 | Common Stock |
| Peter S. Garcia | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2021 | 6,128 | 146,289 | - | - | Employee Stock Option (right to buy) | |
| Jaume Pons | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 26 Jan 2021 | 10,000 | 551,346 | - | 1.0 | 9,900 | Common Stock |
| Jaume Pons | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jan 2021 | 10,000 | 252,179 | - | - | Employee Stock Option (right to buy) | |
| Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 76.00 per share. | 14 Dec 2020 | 20,000 | 995,000 | - | 76 | 1,520,000 | Common Stock |
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 93,969 | 113,287 | - | - | Common Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 52,647 | 54,083 | - | - | Common Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 3,100,020 | 0 | - | - | Series A Convertible Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 2,398,588 | 0 | - | - | Series A Convertible Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 3,100,020 | 3,969,789 | - | - | Common Stock | ||
| Corey S. Goodman | Other, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 850,000 | 850,000 | - | 19 | 16,150,000 | Common Stock |
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 15,794 | 0 | - | - | Series B Convertible Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 3,941,949 | 5,268,325 | - | - | Common Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 78,175 | 0 | - | - | Series A Convertible Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 52,647 | 0 | - | - | Series C Convertible Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 490,411 | 0 | - | - | Series B Convertible Stock | ||
| Corey S. Goodman | Other, Executive Chairman | 21 Jul 2020 | 1,052,950 | 0 | - | - | Series C Convertible Stock | ||
| Peter S. Garcia | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 3,000 | 3,000 | - | 19 | 57,000 | Common Stock |
| Steffen Pietzke | VP Fin & Chief Acct Officer | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 3,000 | 3,000 | - | 19 | 57,000 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 10,529 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 11,110 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 1,831,027 | 2,268,087 | - | - | Common Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 88,704 | 107,220 | - | - | Common Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 150,801 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 8,175 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 59,998 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 39,758 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 683,523 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 222,752 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 1,633,743 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 78,175 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 111,528 | 120,212 | - | - | Common Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 22,000 | 22,000 | - | 19 | 418,000 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 1,498,984 | 2,023,469 | - | - | Common Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 378,000 | 378,000 | - | 19 | 7,182,000 | Common Stock |
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 249,632 | 309,222 | - | - | Common Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 38,660 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 664,660 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 18,705 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Jason Lettmann | Director, Ten Percent Owner | 21 Jul 2020 | 137,286 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Rekha Hemrajani | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 3,000 | 3,000 | - | 19 | 57,000 | Common Stock |
| Graham Walmsley | Director | Purchase of securities on an exchange or from another person at price $ 19.00 per share. | 21 Jul 2020 | 975,000 | 975,000 | - | 19 | 18,525,000 | Common Stock |
| Graham Walmsley | Director | 21 Jul 2020 | 2,105,901 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Graham Walmsley | Director | 21 Jul 2020 | 2,105,901 | 2,161,981 | - | - | Common Stock | ||
| Jaume Pons | Director, President and CEO | 21 Jul 2020 | 27,292 | 541,346 | - | - | Common Stock | ||
| Jaume Pons | Director, President and CEO | 21 Jul 2020 | 1,803 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Jaume Pons | Director, President and CEO | 21 Jul 2020 | 5,264 | 0 | - | - | Series C Convertible Preferred Stock | ||
| Jaume Pons | Director, President and CEO | 21 Jul 2020 | 20,225 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Nathan Caffo | Chief Business Officer | 21 Jul 2020 | 10,529 | 11,254 | - | - | Common Stock | ||
| Nathan Caffo | Chief Business Officer | 21 Jul 2020 | 10,529 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Corey S. Goodman | Other, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 24,009 | 24,009 | - | - | Stock Option (right to buy) | |
| Peter S. Garcia | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 88,137 | 88,137 | - | - | Employee Stock Option (right to buy) | |
| Jack B. Nielsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 24,009 | 24,009 | - | - | Stock Option (right to buy) | |
| Steffen Pietzke | VP Fin & Chief Acct Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 41,789 | 41,789 | - | - | Employee Stock Option (right to buy) | |
| Jason Lettmann | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 24,009 | 24,009 | - | - | Stock Option (right to buy) | |
| Graham Walmsley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 24,009 | 24,009 | - | - | Stock Option (right to buy) | |
| Jaume Pons | Director, President &CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 272,771 | 272,771 | - | - | Employee Stock Option (right to buy) | |
| Nathan Caffo | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 22,794 | 22,794 | - | - | Employee Stock Option (right to buy) | |
| Sophia Randolph | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 89,657 | 89,657 | - | - | Employee Stock Option (right to buy) |